SCHEMBL6813229

SCHEMBL6813229

CCNC(Cc1cnccn1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
THRB P10828 1/20 0.42
CYP3A4 P08684 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2D6 P10635 1/20 0.41
LMNA P02545 2/20 0.40
KDM4E B2RXH2 2/20 0.40
HTT P42858 2/20 0.40
HPGD P15428 2/20 0.37
VNN1 O95497 1/20 0.37
KCNK3 O14649 2/20 0.37
PSMB5 P28074 1/20 0.37
CFTR P13569 1/20 0.36
GOPC Q9HD26 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6814523 0.99 GAA (0.41) GAATHRBCYP3A4CYP1A2CYP2C9
SCHEMBL8862553 0.85 CYP1A2 (0.43) GAATHRBCYP3A4CYP1A2CYP2C9
Hydrochloric Acid SCHEMBL8862777 0.84 CYP3A4 (0.42) GAATHRBCYP3A4CYP1A2CYP2C9
SCHEMBL22457837 0.83 GRIN2D (0.54) CYP1A2CYP2C19CYP2D6LMNAKDM4E
SCHEMBL8862948 0.82 CYP3A4 (0.41) GAATHRBCYP3A4CYP1A2CYP2C9
SCHEMBL9368319 0.79 PDE4A (0.41) GAACYP3A4CYP1A2CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL8862706 0.78 PDE4A (0.40) CYP3A4CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL13523744 0.76 MAOA (0.44) GAATHRBCYP3A4CYP1A2CYP2C9
SCHEMBL9570946 0.75 CYP1A2 (0.44) CYP3A4CYP1A2CYP2C9CYP2C19CYP2D6
Fumaric Acid SCHEMBL8863069 0.74 GAA (0.41) GAATHRBCYP3A4CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1073431-B1 USE OF NMDA ANTAGONISTS FOR TREATMENT OF IRRITABLE BOWEL SYNDROME ASTRAZENECA AB (SE) 2004-07-07 EP claimed
EP-0612314-B1 2-PYRAZINYLETHYLAMINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS ASTRA AB (SE) 1999-12-29 EP claimed
US-5607935-A 2-heterocyclicethylamine derivatives and their use as pharmaceuticals FISONS CORPORATION (US) 1997-03-04 US claimed
EP-0540318-A1 2-Heterocyclicethylamine derivatives and their use as pharmaceuticals FISONS CORPORATION (US) 1993-05-05 EP claimed